We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TARO market cap is 1.61B. The company's latest EPS is USD 1.4334 and P/E is 29.98.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 146.59M | 158.89M | 148.2M | 157.15M | 164.94M |
| Operating Income | 9.27M | -7.92M | 4.74M | 15.91M | 8.79M |
| Net Income | 6.91M | 10.03M | 8.55M | 20.21M | 15.08M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 644.77M | 548.97M | 561.35M | 572.95M | 629.18M |
| Operating Income | 246.54M | -413.78M | 63.47M | 17.71M | 21.51M |
| Net Income | 244.24M | -386.65M | 58.27M | 25.45M | 53.87M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.14B | 2.14B | 2.12B | 2.16B | 2.16B |
| Total Liabilities | 404.66M | 396.52M | 371.92M | 384.09M | 369.06M |
| Total Equity | 1.73B | 1.74B | 1.75B | 1.78B | 1.79B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.34B | 2.41B | 2.18B | 2.14B | 2.16B |
| Total Liabilities | 231.49M | 711.42M | 464.92M | 404.65M | 369.06M |
| Total Equity | 2.11B | 1.7B | 1.71B | 1.73B | 1.79B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 31.75M | 7.78M | 55.29M | 86.22M | 124.56M |
| Investing | -125.56M | -38.7M | 59.87M | 141.54M | 84.34M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 271.61M | 45.77M | -158.7M | 31.75M | 124.56M |
| Investing | -298.16M | 67.74M | -170.58M | -125.56M | 84.34M |
| Financing | -26.98M | -24.2M | -24.93M | N/A | N/A |
| Market Cap | 1.61B |
| Price to Earnings Ratio | 29.98 |
| Price to Sales Ratio | 2.57 |
| Price to Cash Ratio | 4.45 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 37.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.47 (5.62%) |
| Company Name | Taro Pharmaceutical Industries Ltd |
| Address |
14 hakitor street haifa, north 2624761 |
| Website | https://www.taro.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
